Close Menu

One Step Down

IBM has developed lab-on-a-chip diagnostic tool, reports Technology Review. In the prototype, a small amount of blood flows through the chips' capillaries — as small as 30 micrometers. There, antibodies bind to disease markers in the blood, to diagnose a disease in 15 minutes, according to Emmanuel Delamarche who worked on the device at IBM Zurich Research Laboratory. Those compounds are then detected by another set of antibodies and measured with a fluoresce reader.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.